Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope

scientific article

Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1000163540
P356DOI10.1186/1471-2180-4-29
P3181OpenCitations bibliographic resource ID4103192
P932PMC publication ID499545
P698PubMed publication ID15260888
P5875ResearchGate publication ID8448479

P2093author name stringYan Chen
Richard Schlegel
Hang Yuan
Vanessa A Olcese
P2860cites workStructure of small virus-like particles assembled from the L1 protein of human papillomavirus 16Q27625236
Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotidesQ28291604
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccineQ31961522
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.Q32180102
Papillomavirus-like particle vaccines for cervical cancerQ33632759
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomasQ33707499
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1Q33813986
Immunization with a pentameric L1 fusion protein protects against papillomavirus infectionQ33853398
Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress reportQ34089078
Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a reviewQ34206262
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study GroupQ34313864
Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein.Q35228223
Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in miceQ35553171
Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.Q35840539
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.Q35854601
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibitionQ35860748
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotypeQ35867810
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitopeQ35890718
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodiesQ36167475
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteinsQ36637389
Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particlesQ37184404
Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loopsQ37226543
HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domainQ38316465
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomavirusesQ39683911
Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11.Q39875296
Generation and neutralization of pseudovirions of human papillomavirus type 33.Q39879040
A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitopeQ39879423
Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particlesQ41019646
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodiesQ41172103
Papillomavirus-like particles and HPV vaccine developmentQ41585272
Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitopeQ43616965
Identification of Linear Epitopes of the BPV-1 LI Protein Recognized by Sera of Infected or Immunized AnimalsQ43664741
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV typesQ43809054
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infectionQ44238190
A controlled trial of a human papillomavirus type 16 vaccineQ44366335
Human papillomavirus type 6 virus-like particles present overlapping yet distinct conformational epitopesQ44456595
A novel human papillomavirus type 6 neutralizing domain comprising two discrete regions of the major capsid protein L1.Q45065443
Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopesQ45753712
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.Q45767220
Natural history of cervicovaginal papillomavirus infection in young women.Q50909200
Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV InfectionQ57089453
Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptidesQ67674743
Immunological analyses of human papillomavirus capsidsQ73414358
A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human seraQ73685389
A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteersQ73799944
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)29
P577publication date2004-07-19
P1433published inBMC MicrobiologyQ15759430
P1476titleCharacterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope
P478volume4